Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2503-2511

  Danilchanka, Olga ^a   Mailaender, Claudia ^b   Niederweis, Michael ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; HYGROMYCIN B; KANAMYCIN; LEVOFLOXACIN; LIPOARABINOMANNAN; NOVOBIOCIN; OFLOXACIN; RESERPINE; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIUM MUTANT; GENE EXPRESSION; GENE INSERTION; LIPID COMPOSITION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSPOSON;

AMPICILLIN RESISTANCE; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIDIUM; GENES, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; TRANSCRIPTION, GENETIC; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 46249102682     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00298-08     Document Type: Article

References (57)

1. Ahmed, M., C. M. Borsch, A. A. Neyfakh, and S. Schuldiner. 1993. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268:11086-11089.
2. Ainsa, J. A., M. C. Blokpoel, I. Otal, D. B. Young, K. A. De Smet, and C. Martin. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J. Bacteriol. 180:5836-5843.
3. Alahari, A., N. Saint, S. Campagna, V. Molle, G. Molle, and L. Kremer. 2007. The N-terminal domain of OmpATb is required for membrane translocation and pore-forming activity in mycobacteria. J. Bacteriol. 189:6351-6358.
4. Bashyam, M. D., and A. K. Tyagi. 1998. Identification and analysis of "extended - 10" promoters from mycobacteria. J. Bacteriol. 180:2568-2573.
5. Bhatt, A., N. Fujiwara, K. Bhatt, S. S. Gurcha, L. Kremer, B. Chen, J. Chan, S. A. Porcelli, K. Kobayashi, G. S. Besra, and W. R. Jacobs, Jr. 2007. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. USA 104:5157-5162.
6. Braibant, M., P. Gilot, and J. Content. 2000. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol. Rev. 24:449-467.
7. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
8. Briken, V., S. A. Porcelli, G. S. Besra, and L. Kremer. 2004. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53:391-403.
9. Chakrabarti, A. C., and D. W. Deamer. 1992. Permeability of lipid bilayers to amino acids and phosphate. Biochim. Biophys. Acta 1111:171-177.
10. Chambers, H. F., D. Moreau, D. Yajko, C. Miick, C. Wagner, C. Hackbarth, S. Kocagoz, E. Rosenberg, W. K. Hadley, and H. Nikaido. 1995. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob. Agents Chemother. 39:2620-2624.
11. Chambers, H. F., J. Turner, G. F. Schecter, M. Kawamura, and P. C. Hopewell. 2005. Imipenem for treatment of tuberculosis in mice and humans. Antimicrob. Agents Chemother. 49:2816-2821.
12. Chouchani, C., R. Berlemont, A. Masmoudi, M. Galleni, J. M. Frere, O. Belhadj, and K. Ben-Mahrez. 2006. A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica serovar Infantis. Antimicrob. Agents Chemother. 50:3183-3185.
13. Converse, S. E., J. D. Mougous, M. D. Leavell, J. A. Leary, C. R. Bertozzi, and J. S. Cox. 2003. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. USA 100:6121-6126.
14. Delogu, G., C. Pusceddu, A. Bua, G. Fadda, M. J. Brennan, and S. Zanetti. 2004. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol. Microbiol. 52: 725-733.
15. De Rossi, E., J. A. Ainsa, and G. Riccardi. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36-52.
16. De Rossi, E., M. C. Blokpoel, R. Cantoni, M. Branzoni, G. Riccardi, D. B. Young, K. A. De Smet, and O. Ciferri. 1998. Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob. Agents Chemother. 42:1931-1937.
17. Domenech, P., M. B. Reed, and C. E. Barry III. 2005. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73:3492-3501.
18. Farrow, M. F., and E. J. Rubin. 2008. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J. Bacteriol. 190:1783-1791.
19. Flores, A. R., L. M. Parsons, and M. S. Pavelka, Jr. 2005. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 151: 521-532.
20. Franzblau, S. G., R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
21. Gokhale, R. S., P. Saxena, T. Chopra, and D. Mohanty. 2007. Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial lipids. Nat. Prod. Rep. 24:267-277.
22. Harries, A. D., and C. Dye. 2006. Tuberculosis. Ann. Trop. Med. Parasitol. 100:415-431.
23. Hernandez-Alles, S., M. Conejo, A. Pascual, J. M. Tomas, V. J. Benedi, and L. Martinez-Martinez. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273-277.
24. Hillmann, D., I. Eschenbacher, A. Thiel, and M. Niederweis. 2007. Expression of the major porin gene mspA is regulated in Mycobacterium smegmatis. J. Bacteriol. 189:958-967.
25. Huda, N., E. W. Lee, J. Chen, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47:2413-2417.
26. Kaps, I., S. Ehrt, S. Seeber, D. Schnappinger, C. Martin, L. W. Riley, and M. Niederweis. 2001. Energy transfer between fluorescent proteins using a coexpression system in Mycobacterium smegmatis. Gene 278:115-124.
27. Koch, A. L. 2000. Penicillin binding proteins, beta-lactams, and lactamases: offensives, attacks, and defensive countermeasures. Crit. Rev. Microbiol. 26:205-220.
28. Li, X. Z., and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159-204.
29. Li, X. Z., L. Zhang, and H. Nikaido. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
30. Lubelski, J., W. N. Konings, and A. J. Driessen. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol Rev. 71:463-476.
31. Lynett, J., and R. W. Stokes. 2007. Selection of transposon mutants of Mycobacterium tuberculosis with increased macrophage infectivity identifies fadD23 to be involved in sulfolipid production and association with macrophages. Microbiology 153:3133-3140.
32. Mailaender, C., N. Reiling, H. Engelhardt, S. Bossmann, S. Ehlers, and M. Niederweis. 2004. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis. Microbiology 150:853-864.
33. Margolles, A., M. Putman, H. W. van Veen, and W. N. Konings. 1999. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry 38:16298-16306.
34. Markham, P. N., and A. A. Neyfakh. 2001. Efflux-mediated drug resistance in gram-positive bacteria. Curr. Opin. Microbiol. 4:509-514.
35. Martinez, M. B., M. Flickinger, L. Higgins, T. Krick, and G. L. Nelsestuen. 2001. Reduced outer membrane permeability of Escherichia coli O157:H7: suggested role of modified outer membrane porins and theoretical function in resistance to antimicrobial agents. Biochemistry 40:11965-11974.
36. McAdam, R. A., T. R. Weisbrod, J. Martin, J. D. Scuderi, A. M. Brown, J. D. Cirillo, B. R. Bloom, and W. R. Jacobs, Jr. 1995. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect. Immun. 63:1004-1012.
37. Mehta, P. K., A. K. Pandey, S. Subbian, S. H. El-Etr, S. L. Cirillo, M. M. Samrakandi, and J. D. Cirillo. 2006. Identification of Mycobacterium marivum macrophage infection mutants. Microb. Pathog. 40:139-151.
38. Migliori, G. B., R. Loddenkemper, F. Blasi, and M. C. Raviglione. 2007. 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur. Respir. J. 29:423-427.
39. Nikaido, H. 2001. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell. Dev. Biol. 12:215-223.
40. Pelicic, V., M. Jackson, J. M. Reyrat, W. R. Jacobs, Jr., B. Gicquel, and C. Guilhot. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10955-10960.
41. Piddock, L. J. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev. Microbiol. 4:629-636.
42. Pohl, A., P. F. Devaux, and A. Herrmann. 2005. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim. Biophys. Acta 1733: 29-52.
43. Poole, K. 2004. Resistance to beta-lactam antibiotics. Cell Mol. Life Sci. 61:2200-2223.
44. Prod'hom, G., B. Lagier, V. Pelicic, A. J. Hance, B. Gicquel, and C. Guilhot. 1998. A reliable amplification technique for the characterization of genomic DNA sequences flanking insertion sequences. FEMS Microbiol. Lett. 158: 75-81.
45. Raimondi, A., A. Traverse, and H. Nikaido. 1991. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
46. Ried, G., I. Hindennach, and U. Henning. 1990. Role of lipopolysaccharide in assembly of Escherichia coli outer membrane proteins OmpA, OmpC, and OmpF. J. Bacteriol. 172:6048-6053.
47. Rosas-Magallanes, V., G. Stadthagen-Gomez, J. Rauzier, L. B. Barreiro, L. Tailleux, F. Boudou, R. Griffin, J. Nigou, M. Jackson, B. Gicquel, and O. Neyrolles. 2007. Signature-tagged transposon mutagenesis identifies novel Mycobacterium tuberculosis genes involved in the parasitism of human macrophages. Infect. Immun. 75:504-507.
48. Rubin, E. J., B. J. Akerley, V. N. Novik, D. J. Lampe, R. N. Husson, and J. J. Mekalanos. 1999. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc. Natl. Acad. Sci. USA 96:1645-1650.
49. Ruley, K. M., J. H. Ansede, C. L. Pritchett, A. M. Talaat, R. Reimschuessel, and M. Trucksis. 2004. Identification of Mycobacterium marinum virulence genes using signature-tagged mutagenesis and the goldfish model of mycobacterial pathogenesis. FEMS Microbiol. Lett. 232:75-81.
50. Song, H., Y. Wang, R. Sandie, M. Andrade-Navarro, and M. Niederweis. 24 April 2008, posting date. Identification of outer membrane proteins of Mycobacterium tuberculosis. Tuberculosis. [Epub ahead of print.]
51. Stadthagen, G., M. Jackson, P. Charles, F. Boudou, N. Barilone, M. Huerre, P. Constant, A. Liav, I. Bottova, J. Nigou, T. Brando, G. Puzo, M. Daffe, P. Benjamin, S. Coade, R. S. Buxton, R. E. Tascon, A. Rae, B. D. Robertson, D. B. Lowrie, D. B. Young, B. Gicquel, and R. Griffin. 2006. Comparative investigation of the pathogenicity of three Mycobacterium tuberculosis mutants defective in the synthesis of p-hydroxybenzoic acid derivatives. Microbes Infect. 8:2245-2253.
52. Stahl, C., S. Kubetzko, I. Kaps, S. Seeber, H. Engelhardt, and M. Niederweis. 2001. MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 40:451-464 (Authors' correction, 57:1509, 2005).
53. Stephan, J., J. Bender, F. Wolschendorf, C. Hoffmann, E. Roth, C. Mailänder, H. Engelhardt, and M. Niederweis. 2005. The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients. Mol. Microbiol. 58:714-730.
54. Stephan, J., C. Mailaender, G. Etienne, M. Daffe, and M. Niederweis. 2004. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:4163-4170.
55. Takiff, H. E., M. Cimino, M. C. Musso, T. Weisbrod, R. Martinez, M. B. Delgado, L. Salazar, B. R. Bloom, and W. R. Jacobs, Jr. 1996. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 93:362-366.
56. White, V. L., and J. Moore-Gillon. 2000. Resource implications of patients with multidrug resistant tuberculosis. Thorax 55:962-963.
57. Wright, G. D. 2003. Mechanisms of resistance to antibiotics. Curr. Opin. Chem. Biol. 7:563-569.